BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 21796934)

  • 1. Synthesis and antitumor activity against HepG-2, PC-3, and HCT-116 cells of some naphthyridine and pyranopyridinecarbonitrile derivatives.
    Mohamed SF; Abdel-Hafez NA; Amr AE; Awad HM
    Russ J Gen Chem; 2017; 87(6):1264-1274. PubMed ID: 32288469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzimidazole derivatives as potential anticancer agents.
    El Rashedy AA; Aboul-Enein HY
    Mini Rev Med Chem; 2013 Mar; 13(3):399-407. PubMed ID: 23190032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticancer activity of novel benzimidazole and benzothiazole derivatives against HepG2 liver cancer cells.
    Youssef AM; Malki A; Badr MH; Elbayaa RY; Sultan AS
    Med Chem; 2012 Mar; 8(2):151-62. PubMed ID: 22385181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era.
    Yadav S; Narasimhan B; Kaur H
    Anticancer Agents Med Chem; 2016; 16(11):1403-1425. PubMed ID: 26526461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel benzimidazole analogs as inhibitors of EGFR tyrosine kinase.
    Yadav S; Sinha D; Singh SK; Singh VK
    Chem Biol Drug Des; 2012 Oct; 80(4):625-30. PubMed ID: 22564276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
    Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
    Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress of research on anti-tumor agents using benzimidazole as the structure unit.
    Wu K; Peng X; Chen M; Li Y; Tang G; Peng J; Peng Y; Cao X
    Chem Biol Drug Des; 2022 May; 99(5):736-757. PubMed ID: 35064629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry.
    Keri RS; Hiremathad A; Budagumpi S; Nagaraja BM
    Chem Biol Drug Des; 2015 Jul; 86(1):19-65. PubMed ID: 25352112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis,
    Khan S; Iqbal S; Taha M; Hussain R; Rahim F; Shah M; Awwad NS; Ibrahium HA; Alahmdi MI; Dera AA; Ullah H; Bahadur A; Aljazzar SO; Elkaeed EB; Rauf M
    Front Chem; 2023; 11():1125915. PubMed ID: 37214481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Anticancer Profile of New 4-(1
    Abdel-Maksoud MS; Mohamed AAB; Hassan RM; Abdelgawad MA; Chilingaryan G; Selim S; Abdel-Bakky MS; Al-Sanea MM
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.
    Matiadis D; Sagnou M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
    Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
    Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of 3',4',5'-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents.
    Wang Z; Deng X; Xiong R; Xiong S; Liu J; Cao X; Lei X; Chen Y; Zheng X; Tang G
    Medchemcomm; 2018 Feb; 9(2):305-315. PubMed ID: 30108924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Radioiodination and Biodistribution Evaluation of 5-(2-amimo-4-styryl pyrimidine-4-yl)-4-methoxybenzofuran-6-ol.
    Labib AA
    Asia Ocean J Nucl Med Biol; 2013; 1(1):32-8. PubMed ID: 27408840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism.
    Yen TL; Wu MP; Chung CL; Yang WB; Jayakumar T; Geraldine P; Chou CM; Chang CY; Lu WJ; Sheu JR
    J Biomed Sci; 2016 Feb; 23():26. PubMed ID: 26887315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzimidazole derivatives as expected anticancer agents.
    Nofal ZM; Soliman EA; Abd El-Karim SS; El Zahar MI; Srour AM; Sethumadhavan S; Maher TJ
    Acta Pol Pharm; 2011; 68(4):519-34. PubMed ID: 21796934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor and antimicrobial activities of some hetero aromatic benzofurans derived from naturally occurring visnagin.
    El-Nakkady SS; Roaiah HF; El-Serwy WS; Soliman AM; El-Moez SI; Abdel-Rahman AA
    Acta Pol Pharm; 2012; 69(4):645-55. PubMed ID: 22876607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
    El-Said MS; El-Gazzar MG; Al-Dosari MS; Ghorab MM
    Arzneimittelforschung; 2012 Mar; 62(3):149-56. PubMed ID: 22270843
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.